Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2022 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
SNTI on Nasdaq
Shares outstanding
25,375,500
Price per share
$1.41
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
253,755
Total reported value
$357,795
Share change
0
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAYER HEALTHCARE LLC 20% $21,561,396 6,142,848 Bayer HealthCare LLC 10 Mar 2025
Lonsdale Joe 1% 253,755 8VC GP I, LLC 31 Mar 2025

As of 30 Sep 2025, 1 institutional investors reported holding 253,755 shares of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI). This represents 1% of the company’s total 25,375,500 outstanding shares.

Institutional Holders of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 253,755 $357,795 $1.41 1
2025 Q2 253,755 $535,423 $2.11 1
2025 Q1 253,755 $852,617 $3.36 1
2024 Q4 253,755 $890,680 -$108,588 $3.51 1
2024 Q3 301,803 $682,074 -$3,229,188 $2.26 2
2024 Q2 7,852,373 $2,167,022 -$200,932 $0.28 18
2024 Q1 10,994,171 $4,145,409 -$258,280 $0.38 27
2023 Q4 11,461,121 $7,564,707 -$1,232,670 $0.66 25
2023 Q3 12,038,399 $5,018,240 -$89,463 $0.41 24
2023 Q2 12,200,284 $7,637,336 -$267,544 $0.63 27
2023 Q1 12,610,070 $14,256,476 +$192,589 $1.18 24
2022 Q4 12,403,151 $16,580,774 -$1,583,136 $1.41 26
2022 Q3 13,467,057 $27,830,384 +$3,545,952 $2.17 22
2022 Q2 11,902,838 $22,078,000 +$22,077,792 $1.96 17